These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 3562519)

  • 21. [Comparative pharmacokinetics and biologic availability of paracetamol as suppositories].
    Degen J; Maier-Lenz H
    Arzneimittelforschung; 1984; 34(8):900-2. PubMed ID: 6541925
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Bioavailability of acetylsalicylic acid in man. I. Comparative studies of water-soluble and insoluble forms of Polopiryna (Polfa)].
    Wichliński L; Wasiak H; Kanarkowski R
    Acta Pol Pharm; 1977; 34(2):209-14. PubMed ID: 868551
    [No Abstract]   [Full Text] [Related]  

  • 23. [Biologic availability and side-effects of acetosalicylic acid manufactured in Israel and in Europe].
    Landau M; Weiner P; Zach E
    Harefuah; 1985 Sep; 109(5-6):111-3. PubMed ID: 4076901
    [No Abstract]   [Full Text] [Related]  

  • 24. [Comparative pharmacokinetics of salicylic acids administered orally and topically on the skin].
    Gawrońska-Szklarz B; Górnik W; Kustroń B; Wójcicki J; Samochowiec L
    Pol Tyg Lek; 1983 Apr; 38(17):525-7. PubMed ID: 6634501
    [No Abstract]   [Full Text] [Related]  

  • 25. [Utilization of the pharmacokinetic parameters of acetylsalicylic acid for optimizing its use with people of different ages].
    Zapadniuk VI; Korkushko OV; Bezverkhaia IS; Belyĭ AA
    Farmakol Toksikol; 1985; 48(4):69-73. PubMed ID: 4043367
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bioavailability of sustained-release aspirin preparations.
    Lobeck F; Spigiel RW
    Clin Pharm; 1986 Mar; 5(3):236-8. PubMed ID: 3956130
    [No Abstract]   [Full Text] [Related]  

  • 27. [Biologic availability of various preparations of acetylsalicylic acid and their effect on the usefulness of the xylose test in man].
    Markiewicz A
    Pol Arch Med Wewn; 1975 Sep; 54(3):289-95. PubMed ID: 1161546
    [No Abstract]   [Full Text] [Related]  

  • 28. [Comparison of the pharmacokinetic behavior of Turivital, Acesal and Micristin].
    Traeger A; Berlet G; Schröber R; Zaumseil J; Chemnitius KH
    Pharmazie; 1984 Jun; 39(6):409-10. PubMed ID: 6435136
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rectal aspirin--absorption and antipyretic effect.
    Connolly K; Lam L; Ward OC
    Arch Dis Child; 1979 Sep; 54(9):713-5. PubMed ID: 518111
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biopharmaceutical investigations of rectal suppositories. Part 1: Pharmaceutical and biological availability of theophylline.
    Minkov E; Lambov N; Kirchev D; Bantutova I; Tencheva J
    Pharmazie; 1984 Apr; 39(4):242-3. PubMed ID: 6547533
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Rectal absorption of drugs. Influence of the size of acetylsalicylic acid crystals].
    Cid E
    Ann Pharm Fr; 1974 May; 32(5):273-64. PubMed ID: 4433128
    [No Abstract]   [Full Text] [Related]  

  • 32. [Preclinical and clinical pharmacokinetic study of orally administered effervescent acetylsalicylic acid tablets].
    Dévay A; Uderszky J; Tanay J; Nyitrai T; Sátori E; Rácz I
    Acta Pharm Hung; 1985 May; 55(3):114-8. PubMed ID: 4036626
    [No Abstract]   [Full Text] [Related]  

  • 33. [Studies on the influence of uptake conditions on the bioavailability of different acid acetyl salicylic formulations (author's transl)].
    Trublin F; Robert H; Delcambre B
    J Pharm Belg; 1980; 62(6):427-36. PubMed ID: 7463303
    [No Abstract]   [Full Text] [Related]  

  • 34. [The influence of thermal constraints on the liberation of the active principal from the suppository form: the case of acetylsalicylic acid].
    Lasserre Y; Peneva B; Jacob M; Puech A
    J Pharm Belg; 1986; 41(1):12-6. PubMed ID: 3701563
    [No Abstract]   [Full Text] [Related]  

  • 35. [Solitary lesions of the rectum caused by suppositories combining acetylsalicylic acid and paracetamol].
    Lanthier P; Detry R; Debongnie JC; Mahieu P; Vanheuverzwyn R
    Gastroenterol Clin Biol; 1987 Mar; 11(3):250-3. PubMed ID: 3582873
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Biopharmaceutical evaluation of aminophylline suppositories. II. Biological availability of aminophylline (theophylline) from suppositories with normal and prolonged time of total deformation].
    Masiakowski J; Cieszyński T; Dyderski S; Perz A
    Acta Pol Pharm; 1984; 41(1):105-10. PubMed ID: 6496133
    [No Abstract]   [Full Text] [Related]  

  • 37. [Availability of propylphenazone from suppositories. 2. Bioavailability].
    Hackenberger F; Gabrio T; Grune D; Bornschein M; Dietzsch B; Voigt R
    Pharmazie; 1986 Apr; 41(4):244-7. PubMed ID: 3725865
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Relative bioavailability of 2 commercial preparations of aspirin].
    Cedillo Vaz S; Naranjo R; de Vicuña AV
    Acta Cient Venez; 1986; 37(2):202-8. PubMed ID: 3604530
    [No Abstract]   [Full Text] [Related]  

  • 39. [Evaluation of the new formulations of aspirin tablets in bioavailability].
    Bao JX; Fu YK; Xu AX; Li SN; Wu YM
    Yao Xue Xue Bao; 1982 Jul; 17(7):540-5. PubMed ID: 7180486
    [No Abstract]   [Full Text] [Related]  

  • 40. [In vitro absorption of acetylsalicylic acid and some of its alternate pharmaceutical forms].
    Bernabei MT; Forni F; Cameroni R
    Farmaco Prat; 1979 Oct; 34(10):431-9. PubMed ID: 510522
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.